Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination. Photo by Dave Fornell

June 23, 2021 — Findings from a small study detailing the treatment of myocarditis-like symptoms in seven people after receiving a COVID-19 vaccine in the U.S.

June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure.

June 23, 2021 — The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic's Arctic Front Family of cardiac cryoablation catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AFib). The indication is for episodes that last less than seven continuous days and the therapy can be used as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. 

June 22, 2021 — It is no secret that the use of telehealth technologies rose dramatically with the onset of the COVID-19 pandemic. In efforts to keep patients safe, doctors across the country turned to remote patient monitoring (RPM) to evaluate and monitor patients while keeping them at home.

June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being enrolled by the study’s Principal Investigator Allen Jeremias, M.D., at St Francis Hospital in Roslyn, N.Y.

June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate (Pradaxa) anticoagulant oral pellets as the first oral anticoagulant to treat children 3 months to less than 12 years old with venous thromboembolism directly after they have been treated with a blood thinner given by injection for at least five days.

June 18, 2021 — You might be older ― or younger ― than you think. A new study found that differences between a person's age in years and his or her biological age, as predicted by an artificial intelligence (AI)-enabled EKG, can provide measurable insights into health and longevity.

During the COVID-19 pandemic, many cardiology departments were faced with the daunting task of supporting inpatient and outpatient imaging needs, while still addressing ongoing patient safety concerns.

June 16, 2021 — Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software announced that

The integration of a cardiovascular information system (CVIS) with electronic medical records (EMR) ensures a seamless flow of data between providers and helps physicians access a more comprehensive picture of a patient’s medical history, leading to better outcomes.

The integration of a cardiovascular information system (CVIS) with electronic medical records (EMR) ensures a seamless flow of data between providers and helps physicians access a more comprehensive picture of a patient’s medical history, leading to better outcomes.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now